{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:17:17Z","timestamp":1793175437309,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIAAMC"],"published-print":{"date-parts":[[2016,12,23]]},"DOI":"10.2174\/1871523015666160720103732","type":"journal-article","created":{"date-parts":[[2016,7,24]],"date-time":"2016-07-24T05:15:42Z","timestamp":1469337342000},"page":"101-117","source":"Crossref","is-referenced-by-count":11,"title":["Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)"],"prefix":"10.2174","volume":"15","author":[{"given":"Jatinder","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMJ","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/144087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T06:49:37Z","timestamp":1494398977000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5230&volume=15&issue=2&spage=101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12,23]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871523015666160720103732","relation":{},"ISSN":["1871-5230"],"issn-type":[{"value":"1871-5230","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}